The best indicator for Regency Centers (REG)
We backtested 20 indicators across daily, weekly and hourly charts on real Regency Centers (REG) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
SMA 50/200 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Regency Centers (REG) over ~32.6 years — trailing buy-and-hold by 1.9% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | SMA 50/200 Cross ✓ | Daily | 8.1% | 0.54 | -46.9% | 52.0% | 25 | -1.9% |
| 2 | EMA 20/50 Cross ✓ | Weekly | 8.0% | 0.54 | -44.0% | 50.0% | 14 | -1.9% |
| 3 | EMA 50/200 Cross ✓ | Daily | 7.4% | 0.5 | -51.8% | 39.1% | 23 | -2.6% |
| 4 | WaveTrend (8/6/4) ✓ | Daily | 7.7% | 0.42 | -54.4% | 68.2% | 129 | -2.3% |
| 5 | Stochastic ✓ | Weekly | 7.0% | 0.42 | -49.1% | 85.3% | 34 | -2.9% |
| 6 | Bollinger Mean-Reversion ✓ | Daily | 5.9% | 0.4 | -50.7% | 72.4% | 134 | -4.1% |
| 7 | Stochastic ✓ | Daily | 6.3% | 0.4 | -67.4% | 75.0% | 172 | -3.7% |
| 8 | Williams %R ✓ | Daily | 5.9% | 0.38 | -65.3% | 70.6% | 218 | -4.0% |
| 9 | Donchian Breakout | Weekly | 4.4% | 0.37 | -44.5% | 57.7% | 26 | -5.5% |
| 10 | Donchian Breakout ✓ | Daily | 4.6% | 0.35 | -33.2% | 51.6% | 122 | -5.4% |
| 11 | CCI ✓ | Weekly | 5.0% | 0.34 | -49.1% | 94.3% | 35 | -4.9% |
| 12 | CCI ✓ | Daily | 5.0% | 0.33 | -58.1% | 71.7% | 152 | -4.9% |
| 13 | Holy Grail Confluence ✓ | Daily | 4.9% | 0.33 | -55.7% | 84.8% | 46 | -5.0% |
| 14 | Williams %R ✓ | Weekly | 5.1% | 0.33 | -54.5% | 85.1% | 47 | -4.8% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Regency Centers (REG), SMA 50/200 Cross on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.